Table 2.

Impact of COVID-19 on respondents’ ability to care for patients with NCDs and depression or anxiety

	GP (N = 951)	Pharmacists (N = 387)	P value
Care of patients with NCDs
Care has improved	199 (21.1)	187 (48.6)
No change in care	309 (32.7)	98 (26.1)
Care has deteriorated	428 (45.1)	88 (23.7)
			<0.0001
Care of patients with depression or anxiety
Care has improved	299 (31.5)	184 (47.8)
No change in care	320 (33.9)	121 (31.3)
Care has deteriorated	317 (33.5)	63 (16.5)
			<0.0001
Extent to which care was impacted by public health measures
Not at all	48 (5.1)	44 (11.4)
Somewhat impacted	219 (23.1)	142 (36.7)
Moderately impacted	296 (31.3)	96 (24.8)
Significantly impacted	379 (40.1)	89 (23.5)
			<0.0001